Eleusis
Leusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $976k | Convertible | |
| N/A | £3.6m | Series A | |
| N/A | N/A | Series A | |
| N/A | N/A | - | |
* | N/A | Acquisition | |
| Total Funding | AUD8.9m | ||
Related Content
Recent News about Eleusis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.